To estimate the cost per skeletal-related event (SRE) in patients with bone metastases secondary to solid tumours in the Spanish healthcare setting. METHODS: Patients diagnosed with bone metastases secondary to breast, prostate or lung cancer were included in this multicentre, observational study. SREs are defined as pathologic fracture (vertebral and non-vertebral fracture), radiation to bone, spinal cord compression or surgery to bone. Health resource utilisation associated with these events (inpatient stays, outpatient, emergency room and home health visits, nursing home stays and procedures) were collected retrospectively for all SREs that occurred in the 97 days prior to enrolment and prospectively during follow-up. Unit costs were o...
This study aimed to increase the understanding of health resource utilization (HRU) associated with ...
Abstract Background To estimate the costs (paid amounts) of palliative radiation episodes of care (R...
Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer ...
The Author(s) 2013. This article is published with open access at Springerlink.com Purpose To estima...
To estimate the cost per skeletal-related event (SRE) in patients with bone metastases secondary to ...
Abstract Objectives: More than 1.5 million patients worldwide are affected by bone metastases. Patie...
AbstractBackgroundSkeletal-related events (SREs) occur frequently in patients with bone metastases a...
Background: Skeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, spinal...
Background: Bone complications, also known as skeletal-related events (SREs), are common in patients...
IntroductionPrevious studies have estimated the costs of skeletal-related events (SREs) for patients...
BACKGROUND: Skeletal-related events (SREs) occur frequently in patients with bone metastases as a r...
AbstractBackgroundSkeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, ...
Item does not contain fulltextAIM: To assess the resource use and associated costs of treating patie...
International audienceINTRODUCTION: The aim of this prospective, observational, multicenter study wa...
Background Skeletal-related events (SREs; pathologic fracture [PF], spinal cord compression and radi...
This study aimed to increase the understanding of health resource utilization (HRU) associated with ...
Abstract Background To estimate the costs (paid amounts) of palliative radiation episodes of care (R...
Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer ...
The Author(s) 2013. This article is published with open access at Springerlink.com Purpose To estima...
To estimate the cost per skeletal-related event (SRE) in patients with bone metastases secondary to ...
Abstract Objectives: More than 1.5 million patients worldwide are affected by bone metastases. Patie...
AbstractBackgroundSkeletal-related events (SREs) occur frequently in patients with bone metastases a...
Background: Skeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, spinal...
Background: Bone complications, also known as skeletal-related events (SREs), are common in patients...
IntroductionPrevious studies have estimated the costs of skeletal-related events (SREs) for patients...
BACKGROUND: Skeletal-related events (SREs) occur frequently in patients with bone metastases as a r...
AbstractBackgroundSkeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, ...
Item does not contain fulltextAIM: To assess the resource use and associated costs of treating patie...
International audienceINTRODUCTION: The aim of this prospective, observational, multicenter study wa...
Background Skeletal-related events (SREs; pathologic fracture [PF], spinal cord compression and radi...
This study aimed to increase the understanding of health resource utilization (HRU) associated with ...
Abstract Background To estimate the costs (paid amounts) of palliative radiation episodes of care (R...
Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer ...